Synopsis
This book gives a comprehensive overview of disease-modifying antirheumatic drugs (DMARDs). The introductory general chapters deal with the chemistry of DMARDs, their use in therapy, pharmacoeconomics, and a survey of opinion leaders in the field; the following specific chapters characterize each agent with regard to mechanism of action, therapy, pharmacology, efficacy, toxicity, and monitoring. For each agent some background is given, recent developments and influence of the treatment on patients quality of life and long-term outcomes are presented.
"synopsis" may belong to another edition of this title.
Synopsis
This book gives a comprehensive overview of disease-modifying antirheumatic drugs (DMARDs). The introductory general chapters deal with the chemistry of DMARDs, their use in therapy, pharmacoeconomics, and a survey of opinion leaders in the field; the following specific chapters characterize each agent with regard to mechanism of action, therapy, pharmacology, efficacy, toxicity, and monitoring. For each agent some background is given, recent developments and influence of the treatment on patients quality of life and long-term outcomes are presented.
"About this title" may belong to another edition of this title.
Other Popular Editions of the Same Title
Search results for Antirheumatic Therapy: Actions and Outcomes (Progress...
Stock Image
Antirheumatic Therapy : Actions and Outcomes; (Progress in Inflammation Research Series)
Published by
Birkhauser, Switzerland, 2005
ISBN 10: 3764365951
ISBN 13: 9783764365950
Used
Hardcover
Seller: The Book Exchange, Macclesfield, CHESH, United Kingdom
Seller rating 5 out of 5 stars
Hardcover. Condition: Near Fine. No Jacket. 3764365951. Pictorial board hardcover, from closed pharmaceutical company library. Lending record shows this book has never been borrowed. 344 pages, index, refs, illustrated with charts, photos and diagrams. A comprehensive overview of disease-modifying antirheumatic drugs (DMARDs). The introductory general chapters deal with the chemistry of DMARDs, their use in therapy, pharmacoeconomics, and a survey of opinion leaders in the field; the following specific chapters characterize each agent with regard to mechanism of action, therapy, pharmacology, efficacy, toxicity, and monitoring. For each agent some background is given, recent developments and influence of the treatment on patients` quality of life and long-term outcomes are presented. Contents clean, tight and bright. Book. Seller Inventory # 028680
Buy Used
£ 12.50
£ 20 shipping
Ships from United Kingdom to U.S.A.
Ships from United Kingdom to U.S.A.
Quantity: 1 available
Stock Image
Antirheumatic Therapy: Actions and Outcomes.
Seller: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Germany
Seller rating 4 out of 5 stars
XII, 343 p. Hardcover Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Gestempelt. Progress in Inflammation Research. Sprache: Englisch. Seller Inventory # 320FB
Stock Image
Antirheumatic Therapy: Actions and Outcomes (Progress in Inflammation Research)
Seller: Lexington Books Inc, Idaho Falls, ID, U.S.A.
Seller rating 5 out of 5 stars
Hardcover. Condition: Good. Good+; Contents are tight and clean; Ex-Library; Hard Cover; Birkhauser; 2005; 0. Seller Inventory # 80017
Stock Image
Antirheumatic Therapy: Actions and Outcomes (Progress in Inflammation Research)
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
Condition: New. In. Seller Inventory # ria9783764365950_new
Buy New
£ 148.08
£ 11.98 shipping
Ships from United Kingdom to U.S.A.
Ships from United Kingdom to U.S.A.
Quantity: Over 20 available
Seller Image
Anti-Inflammatory or Anti-Rheumatic Drugs
Published by
Springer, Basel, Birkhäuser Basel Dez 2004, 2004
ISBN 10: 3764365951
ISBN 13: 9783764365950
New
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Seller rating 5 out of 5 stars
Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Our goal for this book is to examine the contemporary therapy of rheumatoid arthritis (RA) from the increasingly important perspective of impact upon quality of life, costs and long-term health outcomes. For too long the focus has been on short term, symptomatic, and surrogate indicator outcomes. Yet RA is a life-long disor der with the majority of impact on an individual patient many years following onset. Further, even in the short-term, researchers and rheumatologists have tended to emphasize measurements of disease activity such as joint counts, ESR and physi cian's opinion as to the amount of disease activity present. It is only relatively recently that measures of structural damage, quality of life and impact on broad domains of health have been given increasing emphasis. Also, the significance of early treatment of RA in order to optimise long-term outcomes has a relatively short history [1]. We have been focussed on the disease processes as surrogates for long term outcomes. Until the short-term process measures are validated as surrogates of long-term effects we should also turn our attention to outcomes of disease and the impact of our management on those outcomes [2). Inour view, this book is especially timely. We are at the dawn of a revolution in the management of RA and other complex immunological inflammatory disorders because their molecular, genetic and environmental mechanisms are being unrav elled. Inthe process, we are revealing a substantial number of novel and significant targets for pharmacotherapy. 343 pp. Englisch. Seller Inventory # 9783764365950
Seller Image
Anti-Inflammatory or Anti-Rheumatic Drugs
Print on DemandSeller: moluna, Greven, Germany
Seller rating 5 out of 5 stars
Gebunden. Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Comprehensive and well structured according to classes of agentsIncludes an outlook on future molecular targetsInternational authorshipOur goal for this book is to examine the contemporary therapy of rheumatoid arthritis (RA) from the inc. Seller Inventory # 5279460
Buy New
£ 119.48
£ 41.74 shipping
Ships from Germany to U.S.A.
Ships from Germany to U.S.A.
Quantity: Over 20 available
Stock Image
Antirheumatic Therapy
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
Seller rating 5 out of 5 stars
Condition: New. Offering an overview of disease-modifying antirheumatic drugs (DMARDs), this book deals with the chemistry of DMARDs, their use in therapy, pharmacoeconomics, and a survey of opinion leaders in the field. It also characterizes each agent with regard to mechanism of action, therapy, pharmacology, efficacy, toxicity, and monitoring. Editor(s): Day, Richard O.; Furst, Daniel E.; Van Riel, Piet L.; Bresnihan, Barry. Series: Progress in Inflammation Research. Num Pages: 356 pages, biography. BIC Classification: MJM; MMG. Category: (P) Professional & Vocational; (U) Tertiary Education (US: College). Dimension: 240 x 168 x 21. Weight in Grams: 782. . 2004. Hardback. . . . . Seller Inventory # V9783764365950
Seller Image
Antirheumatic Therapy: Actions and Outcomes
Print on DemandSeller: preigu, Osnabrück, Germany
Seller rating 5 out of 5 stars
Buch. Condition: Neu. Antirheumatic Therapy: Actions and Outcomes | Richard O. Day (u. a.) | Buch | xiii | Englisch | 2004 | Springer Basel | EAN 9783764365950 | Verantwortliche Person für die EU: Springer Basel AG in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand. Seller Inventory # 102445756
Seller Image
Antirheumatic Therapy: Actions and Outcomes
Published by
Birkhäuser Basel, Birkhäuser Basel Dez 2004, 2004
ISBN 10: 3764365951
ISBN 13: 9783764365950
New
Hardcover
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany
Seller rating 5 out of 5 stars
Buch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Our goal for this book is to examine the contemporary therapy of rheumatoid arthritis (RA) from the increasingly important perspective of impact upon quality of life, costs and long-term health outcomes. For too long the focus has been on short term, symptomatic, and surrogate indicator outcomes. Yet RA is a life-long disor der with the majority of impact on an individual patient many years following onset. Further, even in the short-term, researchers and rheumatologists have tended to emphasize measurements of disease activity such as joint counts, ESR and physi cian's opinion as to the amount of disease activity present. It is only relatively recently that measures of structural damage, quality of life and impact on broad domains of health have been given increasing emphasis. Also, the significance of early treatment of RA in order to optimise long-term outcomes has a relatively short history [1]. We have been focussed on the disease processes as surrogates for long term outcomes. Until the short-term process measures are validated as surrogates of long-term effects we should also turn our attention to outcomes of disease and the impact of our management on those outcomes [2). Inour view, this book is especially timely. We are at the dawn of a revolution in the management of RA and other complex immunological inflammatory disorders because their molecular, genetic and environmental mechanisms are being unrav elled. Inthe process, we are revealing a substantial number of novel and significant targets for pharmacotherapy.Springer Basel AG in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin 364 pp. Englisch. Seller Inventory # 9783764365950
Seller Image
Antirheumatic Therapy: Actions and Outcomes
Published by
Birkhäuser Basel, Birkhäuser Basel, 2004
ISBN 10: 3764365951
ISBN 13: 9783764365950
New
Hardcover
Seller: AHA-BUCH GmbH, Einbeck, Germany
Seller rating 5 out of 5 stars
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Our goal for this book is to examine the contemporary therapy of rheumatoid arthritis (RA) from the increasingly important perspective of impact upon quality of life, costs and long-term health outcomes. For too long the focus has been on short term, symptomatic, and surrogate indicator outcomes. Yet RA is a life-long disor der with the majority of impact on an individual patient many years following onset. Further, even in the short-term, researchers and rheumatologists have tended to emphasize measurements of disease activity such as joint counts, ESR and physi cian's opinion as to the amount of disease activity present. It is only relatively recently that measures of structural damage, quality of life and impact on broad domains of health have been given increasing emphasis. Also, the significance of early treatment of RA in order to optimise long-term outcomes has a relatively short history [1]. We have been focussed on the disease processes as surrogates for long term outcomes. Until the short-term process measures are validated as surrogates of long-term effects we should also turn our attention to outcomes of disease and the impact of our management on those outcomes [2). Inour view, this book is especially timely. We are at the dawn of a revolution in the management of RA and other complex immunological inflammatory disorders because their molecular, genetic and environmental mechanisms are being unrav elled. Inthe process, we are revealing a substantial number of novel and significant targets for pharmacotherapy. Seller Inventory # 9783764365950